Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
429 JPY | -0.69% | +2.14% | -38.75% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Sales 2024 | - | Sales 2025 * | - | Capitalization | 29.65B 192M |
---|---|---|---|---|---|
Net income 2024 | -2.64B -17.1M | Net income 2025 * | -3.3B -21.32M | EV / Sales 2024 | - |
Net cash position 2024 * | 5.65B 36.52M | Net Debt 2025 * | 226M 1.46M | EV / Sales 2025 * | - |
P/E ratio 2024 |
-14
x | P/E ratio 2025 * |
-8.8
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.15% |
Latest transcript on SanBio Company Limited
1 day | +1.41% | ||
1 week | +1.89% | ||
Current month | -2.92% | ||
1 month | -32.50% | ||
3 months | -30.55% | ||
6 months | -27.15% | ||
Current year | -38.46% |
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 13-02-28 |
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Toru Kawanishi
CHM | Chairman | 56 | 13-02-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 429 | -0.69% | 206 700 |
24-04-18 | 432 | +1.41% | 458,400 |
24-04-17 | 426 | +3.65% | 883,400 |
24-04-16 | 411 | -1.20% | 460,100 |
24-04-15 | 416 | -1.19% | 289,800 |
Delayed Quote Japan Exchange, April 18, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.46% | 189M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- 4592 Stock